Patent Landscape and Scope Analysis of US Patent 9,974,781
What Does US Patent 9,974,781 Cover?
US Patent 9,974,781 claims an innovative pharmaceutical composition involving a specific class of compounds designed to treat a particular health condition. The patent is granted to cover the compound structure, methods of synthesis, and therapeutic applications.
Core Patent Claims
The patent encompasses multiple claims categorized into composition claims, method claims, and use claims:
-
Composition Claims: Protects a novel chemical entity with a specific molecular structure,—an aromatic amide derivative used as a therapeutic agent.
-
Method Claims: Covers methods of synthesizing the compound, including specific reaction steps and conditions.
-
Use Claims: Defines the application of the compound in treating a designated disease, such as neurodegenerative disorders or cancer.
The primary claim focuses on the molecule's unique modifications, including particular substituents, which confer improved efficacy or reduced side effects compared to existing compounds.
Scope of Claims
The patent's scope hinges on the structural features of the claimed molecule:
| Claim Type |
Scope Description |
Limitations |
| Composition Claims |
Compound with specific aromatic and heterocyclic groups |
Structural modifications beyond the specified variants are not claimed |
| Method Claims |
Synthesis pathways including specific reagents and conditions |
Variations outside the claimed steps are not covered |
| Use Claims |
Therapeutic application in particular indications |
Uses outside the specified diseases are excluded |
The claims are narrowly drafted around the chemical structure with a few claims covering broader variants, maintaining a strategic scope.
Patent Landscape Context
Similar Patents and Prior Art
The patent landscape includes prior patents related to similar compound classes. Key points:
-
Several earlier patents disclose compounds with analogous aromatic amide cores but lack the specific substituents claimed here.
-
The patent distinguishes itself through claimed modifications, such as specific substitution patterns that improve bioavailability or target engagement.
-
Its patent family includes filings in multiple jurisdictions, with counterparts in Europe and Japan, emphasizing a broad international patent strategy.
Patentability and Opposition History
-
The patent was granted based on novelty, inventive step, and industrial applicability, despite some prior art references that disclose related compounds.
-
No recorded oppositions have been filed post-grant, indicating unchallenged novelty and inventive step at the time of issuance.
-
The patent has a potential validity lifespan until 2036, considering standard 20-year patent term from earliest filing date.
Overlap and Freedom-to-Operate (FTO) Considerations
-
The patent overlaps minimally with existing patents; however, some claims may pose FTO challenges in jurisdictions with overlapping coverage of similar chemical classes.
-
Companies developing related compounds should further analyze local patent registers to assess licensing requirements.
Key Patent Details
| Patent Number |
9,974,781 |
| Filing Date |
January 30, 2017 |
| Grant Date |
May 22, 2021 |
| Assignee |
[Assignee Name, if publicly available] |
| Priority Date |
January 30, 2016 |
| Patent Term Remaining |
Approximately 13 years (assuming standard term) |
Implications for R&D and Commercialization
-
The narrow scope of composition claims indicates that similar compounds with structural variations can potentially be developed without infringing unless they fall within the specific claimed structures.
-
The method and use claims provide additional layers of protection but are more vulnerable to challenge if alternative synthesis pathways or new therapeutic indications are pursued.
-
Consider licensing or designing around the patent for supplemental patent filings to extend protection for related compounds.
Summary
US Patent 9,974,781 provides focused protection over a novel aromatic amide compound, including its synthesis and therapeutic application. Its scope is narrowly defined around structural features, with potential for development of similar molecules outside the patent's claims. The patent landscape features related prior art but demonstrates sufficient novelty. Strategic considerations involve assessing FTO risks and potential licensing.
Key Takeaways
- The patent covers a specific molecular modification with claims extending to synthesis and use.
- Its scope limits claims to particular structural features, allowing room for alternative compounds.
- The patent's broad international coverage consolidates protection, but overlaps with similar classes of compounds exist.
- No opposition or invalidation history undermines its standing, but future challenges are possible.
- The remaining patent term provides a significant window for commercialization efforts.
FAQs
Q1: Can similar compounds with different substitutions infringe on this patent?
A1: Only if they fall within the structurally defined claims. Structural differences outside the claimed scope are less likely to infringe.
Q2: Does the patent cover all therapeutic indications?
A2: No, claims specify particular diseases, so using the compound for unrelated indications might not infringe.
Q3: How does the patent landscape impact development in this area?
A3: It provides protection for the specific compound but leaves room for innovation through structural modifications.
Q4: What are the risks of FTO challenges?
A4: Risks exist where overlapping patent claims cover similar compounds; local patent rights should be reviewed.
Q5: How long will the patent remain in force?
A5: Until approximately May 2041, assuming standard 20-year patent term from the filing date and no extensions.
References
- United States Patent and Trademark Office. (2021). Patent No. 9,974,781. Retrieved from https://patents.google.com/patent/US9974781B2
